Research Progress on the Pharmacological Action of Schisantherin A.

Evid Based Complement Alternat Med

Department of Physiology, Medical College of Nanchang University, Nanchang 330006, China.

Published: February 2022

Schisantherin A (Sch A) is a dibenzocyclooctadiene lignan monomer isolated from the fruit of (Turcz.) Baill. (). At present, many studies have shown that Sch A has a wide range of pharmacological effects, including its anti-Parkinson and anti-inflammatory effects and ability to protect the liver, protect against ischemia-reperfusion (I/R) injury, suppress osteoclast formation, and improve learning and memory. Its mechanism may be related to the antioxidant, anti-inflammatory, and antiapoptotic properties of Sch A through the MAPK, NF-B, AKT/GSK3, and PI3K/AKT pathways. This is the first review of the recent studies on the pharmacological mechanism of Sch A.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858060PMC
http://dx.doi.org/10.1155/2022/6420865DOI Listing

Publication Analysis

Top Keywords

progress pharmacological
4
pharmacological action
4
action schisantherin
4
schisantherin schisantherin
4
sch
4
schisantherin sch
4
sch dibenzocyclooctadiene
4
dibenzocyclooctadiene lignan
4
lignan monomer
4
monomer isolated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!